Leadership: Page 6
-
PharmaVoice 100
PharmaVoice 100s: Cancer care visionaries
Leaders shaping the future of oncology and cancer care through grit and determination in the face of one of healthcare’s greatest challenges.
By Michael Gibney • Oct. 2, 2023 -
The PharmaVoice 100: Trailblazers
Leaders who are going where no biopharma executive has gone before and changing the industry along the way.
By Michael Gibney • Sept. 29, 2023 -
Trendline
Commercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
Pfizer CEO Albert Bourla led Big Pharma bonus payouts over 5 years — but he’s no Elon Musk
A recent report showed how pharma’s bonuses pale in comparison to other industries, but several execs still rake in hefty packages.
By Michael Gibney • Sept. 28, 2023 -
PharmaVoice 100
PharmaVoice 100s: Standout execs
Leaders who’ve created unique strategies for thriving amid the heavy headwinds facing the industry.
By Meagan Parrish • Sept. 25, 2023 -
Sponsored by Astellas
For Astellas’ CMO, accelerating innovation means working at the edge of your comfort zone
Scientific discovery through new, breakthrough modalities is essential to solve current and future global health challenges – but the path is not easy nor well-defined.
Sept. 25, 2023 -
The 2023 PharmaVoice 100
This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.
By Julia Himmel • Sept. 19, 2023 -
Moderna’s bold five-year plan reflects Big Pharma tradition of ‘Will they deliver?’
Forecasts from the biggest pharma companies follow a pattern of thinking big and manifesting the desired outcome.
By Michael Gibney • Sept. 15, 2023 -
Catching up with 2022 PharmaVoice 100 honorees
Tapping into our growing community for expertise and inspiration.
By Meagan Parrish • Sept. 13, 2023 -
A tale of two biotechs — 2seventy, Regeneron announce C-suite shakeups
The biotech’s chief financial officer Robert Landry is retiring in February.
By Karissa Waddick • Sept. 12, 2023 -
Ex-Sanofi executive Sibold joins Madrigal as new CEO
Bill Sibold has led Sanofi's specialty care business unit for the past six years. He replaces Paul Friedman as head of the NASH drug developer.
By Ned Pagliarulo • Sept. 11, 2023 -
Pharma faces a slew of leadership shakeups
Biogen, Sanofi, Bristol Myers Squibb and more have all recently announced major executive changes.
By Karissa Waddick • Sept. 7, 2023 -
Profile
‘Not all rainbows and unicorns’ — a former CEO dishes on his rocky biotech ride
Armon Sharei took his startup SQZ from a graduate project at MIT to a Big Pharma partnership worth $1B+. Despite the company’s stumbles, Sharei’s enthusiasm for biotech’s future remains.
By Michael Gibney • Sept. 7, 2023 -
Roz Brewer announces sudden departure as CEO of Walgreens
The exec who set out to overhaul the long-time pharmacy giant offered few details on why she's stepping down.
By Meagan Parrish • Sept. 1, 2023 -
Q&A // Biotech Spotlight
‘We need to do better:’ A biotech CEO on standing apart from the crowd
The CEO of Cullinan Oncology is taking a small biotech to the next step and believes the temporary financial barriers are smaller than scientific progress.
By Michael Gibney • Aug. 29, 2023 -
How an AstraZeneca exec is leading the charge in the next immuno-oncology era
The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.
By Michael Gibney • Aug. 17, 2023 -
Podcast
Woman of the Week: Novartis’ Christy Siegel
The oncology portfolio general manager for breast and women’s cancers, discusses the company’s recent “landmark” trial and how her family’s history connects her to patients.
By Taren Grom and Meagan Parrish • Aug. 15, 2023 -
Q&A
5 minutes with — Lundbeck CEO Dr. Deborah Dunsire
The long-time pharma exec on her most recent wins, her favorite rule to break and the words she lives by.
By Meagan Parrish • Aug. 11, 2023 -
In the era of blockbuster obesity drugs, a personalized approach could boost outcomes
Ozempic and Wegovy have become household names for weight loss. But obesity is complex, and Phenomix Sciences is looking to bring a personalized medicine approach to the field.
By Michael Gibney • Aug. 8, 2023 -
Q&A // Biotech Spotlight
Why AbbVie’s former president has high hopes for this Flagship-backed biotech
The CEO of Tessera Therapeutics believes the company’s gene writing technology could eventually cure nearly any genetic disease across patient populations.
By Karissa Waddick • Aug. 7, 2023 -
New Alzheimer’s treatments are the tip of the iceberg in a long-stymied area of medicine
A smaller player in the Alzheimer’s space, Prothena is approaching the next phase of treatments, including prevention and clinical trial evolution.
By Michael Gibney • Aug. 3, 2023 -
Biogen’s layoffs are the latest in an industrywide slip
Over 100 biotech companies so far this year have cut staff due to persistent funding challenges.
By Karissa Waddick • July 26, 2023 -
Q&A
A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here
Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.
By Taren Grom and Meagan Parrish • July 20, 2023 -
Profile
What the 2014 Ebola outbreak taught this biotech CEO about persuasion
A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.
By Alexandra Pecci • July 18, 2023 -
Making Moves
Flagship, PhRMA prioritize experience in hot summer exec changes
With major projects brewing at both organizations, these new leaders will hit the ground running.
By Karissa Waddick • July 14, 2023 -
Q&A // First 90 Days
A rare disease veteran, Inozyme’s new CEO sharpens the company’s focus
After taking the reins from the company’s founding CEO, Douglas Treco is guiding Inozyme through the clinic.
By Alexandra Pecci • July 11, 2023